Teleflex

Teleflex Gross Profit/Assets

The Gross Profit to Assets Ratio of Teleflex (TFX) as of Oct 17, 2026 is 16.13 %. In the previous year, Gross Profit to Assets Ratio was 23.99 % — a change of -32.75% (lower).

Gross Profit/Assets

16.13 %

YoY

-32.75%

Last updated:

Gross Profit to Assets Ratio of Teleflex is 2025 16.13 % . Gross Profit to Assets Ratio of Teleflex was 2024 23.99 % . It decreases by -32.75% lower compared to the previous year.

The Teleflex Gross Profit/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit/Assets
Date
Gross Profit/Assets
Jan 1, 2018
22.05 USD
Jan 1, 2019
22.33 USD
Jan 1, 2020
18.52 USD
Jan 1, 2021
22.55 USD
Jan 1, 2022
22.10 USD
Jan 1, 2023
21.86 USD
Jan 1, 2024
23.99 USD
Jan 1, 2025
16.13 USD
The Teleflex Gross Profit/Assets history
YEARGross Profit/AssetsYoY
16.13 %-32.75%
23.99 %+9.72%
21.86 %-1.07%
22.10 %-2.00%
22.55 %+21.74%
18.52 %-17.05%
22.33 %+1.26%
22.05 %+16.33%
18.96 %-25.95%
25.60 %+5.14%
24.35 %+2.76%
23.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Teleflex Stock analysis

What does Teleflex do? Teleflex Inc. is a global company founded in 1943. The company is headquartered in Wayne, Pennsylvania, USA and operates in over 40 countries worldwide. It is a leading provider of medical devices, instruments, and accessories for various applications in clinical practice and patient care. The business model of Teleflex is based on the manufacturing and marketing of medical devices and instruments, particularly in the areas of anesthesia, vascular access, interventional medicine, pulmonary and thoracic surgery, urological care, cardiovascular diagnostics, and surgery. The company works closely with medical professionals and clinicians to develop high-quality products that meet the needs of patients and doctors. Teleflex is divided into several business segments, including angiography/diagnostics, anesthesia, oncology, vascular intervention, pulmonology, surgery, and urology. Each of these segments offers a wide range of products and solutions specifically tailored to the needs of doctors and patients. In the angiography/diagnostics segment, Teleflex offers a variety of products that can be used for the diagnosis and treatment of cardiovascular diseases and other medical conditions. These include catheters, guide wires, and sheaths. The anesthesia segment of Teleflex includes products such as ventilation bags, endotracheal tubes, and nebulizer systems. These products are essential for the successful performance of anesthesia procedures and can help doctors save valuable time and resources. The oncology segment of Teleflex offers a wide range of products specifically designed for the treatment of cancer patients. These include catheter-based systems that can facilitate the administration of drugs and other therapies. With the vascular intervention segment, Teleflex offers a comprehensive range of products and solutions specifically designed for the treatment of vascular diseases. These include balloon catheters, stents, and sheaths. The pulmonology segment of Teleflex offers products aimed at facilitating breathing and improving the quality of life for patients with chronic respiratory diseases. These include oxygen concentrators, tracheal tubes, and ventilators. The surgical segment of Teleflex offers a variety of solutions for performing surgical procedures, including surgical instruments, sutures, and wound care materials. The urology segment of Teleflex offers a wide range of products specifically designed for use in urology. These include catheters, wires, and stents. Teleflex is a leading company in the medical technology industry that specializes in the development and marketing of products that improve patients' quality of life and facilitate the work of doctors. With its innovative solutions and a focus on providing the best possible customer service and patient safety, Teleflex has taken on a significant role in the industry and will continue to be an important provider in this market in the future. Teleflex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Teleflex stock

Gross Profit to Assets Ratio of Teleflex is 16.13 % in 2025.

Gross Profit to Assets Ratio of Teleflex changed from 23.99 % to 16.13 %, representing a -32.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit to Assets Ratio Teleflex since 2006 – with annual values, charts, and detailed analysis.

Gross Profit/Assets measures how efficiently a company uses its assets to generate gross profit. Research shows it is a strong predictor of future stock returns.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Profit to Assets Ratio's Teleflex with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Profit to Assets Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Profit to Assets Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Teleflex

All Key Metrics — Teleflex